Role of transforming growth factor β in breast carcinogenesis

Lancet Oncology

Volumn 5, Issue 4, 2004, Pages 229-239

  Benson, John R ^a,b  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b HINCHINGBROOKE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; HISTONE DEACETYLASE INHIBITOR; MONOCLONAL ANTIBODY; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TUMOR SUPPRESSOR PROTEIN;

ANGIOGENESIS; AUTOCRINE EFFECT; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL CULTURE; CANCER STAGING; CELL PROLIFERATION; EPITHELIUM CELL; GENE OVEREXPRESSION; GROWTH INHIBITION; GROWTH REGULATION; HUMAN; IMMUNE RESPONSE; INHIBITION KINETICS; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; PARACRINE SIGNALING; PATHOPHYSIOLOGY; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; TUMOR GROWTH;

BREAST NEOPLASMS; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; FEMALE; HUMANS; NEOPLASM METASTASIS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 1642359815     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(04)01426-3     Document Type: Review

References (85)

1. Benson JR Colletta AA. Transforming growth factor β-prospects for cancer prevention and treatment Clin Immunother 4 1995 249-258
2. Roberts AB Anzano MA Wakefield LM et al. Transforming growth factor β: a bifunctional regulator of growth Proc Natl Acad Sci USA 82 1985 119-123
3. Robinson SD Silberstein GB Roberts AB et al. Regulated expression and growth inhibitory effects of transforming growth factor β isoforms in mouse mammary gland development Development 113 1991 867-878
4. Wakefield LM Yang Yu-an Dukhanina O. Transforming growth factor β and breast cancer: lessons learned from genetically altered mouse models Breast Cancer Res 2 2000 100-106
5. Roberts AB. Molecular and cell biology of TGFβ Miner Electrolyte Metab 24 1998 111-119
6. Wakefield LM Pick E Bottinger E. TGFβ signalling in mammary gland development and tumorigenesis J Mammary Gland Biol Neoplasia 6 2001 67-81
7. Dickens TA Colletta AA. The pharmacological manipulation of members of the transforming growth factor β family in the chemoprevention of breast cancer Bioessays 15 1993 71-74
8. Benson JR. Role of TGFβ in carcinogenesis and mediation of therapeutic response in breast cancer. In Benson JR (Ed.), TGFβ and cancer 1st edn 1998 113-137 RG Landes Austin Texas
9. Massague J. The transforming growth factor β family Annu Rev Cell Biol 6 1990 597-641
10. Wakefield LM Smith DM Flanders KC Sporn MB. Latent transforming growth factor β from human platelets J Biol Chem 263 1998 7634-7646
11. Crawford SE Stellmach V Murphy-Ullrich JE et al. Thrombospondin-1 is a major activator of TGFβ in vivo Cell 93 1998 1159-1170
12. Munger JS Huang X Kawakatsu H et al. The integrin alpha v beta 6 binds and activates latent TGFβ1: a mechanism for regulating pulmonary inflammation and fibrosis Cell 96 1999 319-328
13. Wrana JL Attissano L Rotraud W et al. Mechanism of activation of the transforming growth factor β receptor Nature 370 1994 341-346
14. Geiser AG Brumester JK Webbink R et al. Inhibition of growth by TGFβ following fusion of two non-responsive human carcinoma cell lines: implication of the type II receptor in growth inhibitory responses J Biol Chem 267 1992 2588-2593
15. Sun L Wu G Willson JKV et al. Expression of transforming growth factor β type II receptor leads to reduced malignancy and in human breast cancer MCF-7 J Biol Chem 269 1994 26449-26455
16. Massague J. TGFβ signal transduction Annu Rev Biochem 67 1998 753-791
17. Tsukazaki T Chiang TA Davison AF et al. SARA, a FYVE domain protein that recruits Smad 2 to the TGFβ receptor Cell 95 1998 779-791
18. Zhang Y Feng X We R Derynck R. Receptor-associated Mad homologues synergise as effectors of the TGFβ response Nature 383 1996 168-172
19. Dai JL Schutte M Bansal RK et al. Transforming growth factor β responsiveness in DPC4/Smad4-null cancer cells Mol Carcinog 26 1999 37-43
20. Wong C Rougier-Chapman EM Frederick JP et al. Smad 3-Smad 4 and AP-1 complexes synergise in transcriptional activation of the c-Jun Promoter by transforming growth factor β Mol Cell Biol 19 1999 1821-1830
21. Zhang Y Feng XH Derynck R. Smad 3 and Smad 4 co-operate with c-Jun/c-fos to mediate TGFβ-induced transcription Nature 394 1998 909-913
22. Peters G. Stifled by inhibitions Nature 371 1994 204-205
23. de Caesteker MP Piek E Roberts A. Role of transforming growth factor-β signalling in cancer J Natl Cancer Inst 92 2000 1388-1402
24. Motakura T Bloom T Kim HG et al. A novel cyclin encoded by a bc11-linked candidate oncogene Nature 350 1991 512-515
25. Tan P Cady B Wanner M et al. The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a, b) invasive breast carcinomas Cancer Res 57 1997 1259-1263
26. Derynck R Akhurst RJ Balmain A. TGFβ signalling in tumour suppression and cancer progression Nat Genet 29 2001 117-129
27. Arteaga CL Tandon AK Von Hoff DD et al. Transforming growth factor β: potential autocrine growth inhibitor of oestrogen receptor negative human breast cancer cells Cancer Res 48 1998 3898-3904
28. Roberts AB McCune BK Sporn MB. TGFβ: regulation of extracellular matrix Kidney Int 41 1992 557-559
29. Alevilopoulos A Mermod N. Transforming growth factor-β: the breaking open of a black box Bioessays 19 1997 581-591
30. McCune BK Mullin BR Flanders KC et al. Localisation of transforming growth factor-β isotypes in lesions of the human breast Hum Pathol 23 1990 13-20
31. MacCallum J Bartlett JMS Thompson AM et al. Expression and distribution of transforming growth factor-β mRNA isoforms in human breast cancer Br J Cancer 69 1994 1006-1009
32. Doetschman T. Interpretation of phenotype in genetically engineered mice Lab Anim Sci 49 1999 137-143
33. Kulkarni AB Thyagarajan T Letterio JJ. Function of cytokines within the TGFβ super family as determined from transgenic and gene knockout studies in mice Curr Mol Med 2 2002 303-327
34. Daniel CW Robinson S Silberstein GB. The role of TGFβ in patterning and growth of the mammary ductal tree J Mammary Gland Biol Neoplasia 1 1996 331-341
35. Chakravarty D Green AR Green V et al. Expression and secretion of TGFβ isoforms and expression of TGFβ receptors I, II and III in normal and neoplastic human breast tissue Int J Oncol 15 1999 187-194
36. Koli KM Arteaga CL. Complex role of tumor cell transforming growth factor-βs on breast carcinoma progression J Mammary Gland Biol Neoplasia 1 1996 373-380
37. Kimchi A wang X-F Weinberg RA et al. Absence of TGFbeta receptors and growth inhibitory responses in retin Annu Rev Cell Biol 6 1990 597-641
38. Vincent F Nagashima M Takenoshita S et al. Mutation analysis of the transforming growth factor- type II receptor in human cell lines resistant to growth inhibition by transforming grown factor-β Oncogene 15 1997 117-122
39. Gobbi H Dupont WD Simpson JF et al. Relationship between TGFβ type II receptor expression and breast cancer risk in women with epithelial hyperplasia lacking atypia J Natl Cancer Inst 91 1999 2096-2101
40. Gobbi H Arteaga CL Jensen RA et al. Loss of expression of transforming growth factor-β type II receptor correlates with high tumor grade in human breast in-situ and invasive carcinomas Histopathology 36 2000 168-177
41. Chen C-R Kang Y Massague J. Defective repression of c-myc in breast cancer cells: a loss at the core of the transforming growth factor β growth arrest program Proc Natl Acad Sci USA 98 2001 992-999
42. Knabbe C Lippman ME Wakefield LM et al. Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer Cell 48 1987 417-428
43. Argeaga CL Coffey RJ Dugger TC et al. Growth stimulation of human breast cancer cells with anti-transforming growth factor-β antibodies Cell Growth Diff 1 1990 367-374
44. Dickson RB Kasid A Huff KK et al. Activation of growth factor secretion in tumorigenic states of breast cancer induced by 17β estradiol or v-Ha-ras oncogene Proc Natl Acad Sci USA 84 1987 837-841
45. Arteaga CL Carty-Dugger T Moses HL et al. Transforming growth factor-β1 can induce estrogen-independent tumorigenicity of human breast cancer cells in athymic mice Cell Growth Diff 4 1993 193-201
46. Dumont N Arteaga CL. Transforming growth factor-β and breast cancer: tumour promoting effects of transforming growth factor-β Breast Cancer Res 2 2000 125-132
47. Gorsch SM Memoli V Stukel TA et al. Immunohistochemical staining for transforming growth factor-β1 associates with disease progression in human breast cancer Cancer Res 52 1992 6949-6952
48. Murray PA Barrett-Lee P Travers M et al. The prognostic significance of transforming growth factors in human breast cancer Br J Cancer 67 1993 1408-1412
49. MacCallum J Keen JC Bartlett JMS et al. Changes in expression of transforming growth factor-β mRNA isoforms in patients undergoing tamoxifen therapy Br J Cancer 74 1996 474-478
50. Thompson AM Kerr DJ Steel CM et al. Transforming growth factor-β1 is implicated in the failure of tamoxifen therapy in human breast cancer Br J Cancer 63 1991 609-614
51. Travers MT Barrett-Lee PJ Berger U et al. Growth factor expression in normal, benign and malignant breast tissue BMJ 296 1988 1621-1624
52. Mizukami Y Nonomura A Yamada T et al. Immunohistochemical demonstration of growth factors TGFα, TGFβ, IGF-I and neu oncogene product in benign and malignant breast tissues Anticancer Res 10 1990 1115-1126
53. Butta A Maclennan K Flanders KC et al. Induction of transforming growth factor-β1 in human breast cancer in vivo following tamoxifen treatment Cancer Res 52 1992 4261-4264
54. Colletta AA Wakefield LM Howell FV et al. Anti-oestrogens induce the secretion of active transforming growth factor-β from human foetal fibroblasts Br J Cancer 62 1990 405-409
55. Benson JR Wakefield LM Baum M Colletta AA. Synthesis and secretion of transforming growth factor-β isoforms by primary cultures of human breast tumour fibroblasts in vitro and their modulation by tamoxifen Br J Cancer 74 1996 352-358
56. Silberstein GB Daniel CW. Reversible inhibition of mammary gland growth by transforming growth factor-β Science 237 1987 291-293
57. Pierce Jr DF Johnson MD Matsui Y et al Inhibition of mammary duct development but not alveolar outgrowth during pregnancy in transgenic mice expressing active TGFβ1 Genes Dev 7 1993 2308-2317
58. Kordon ER McKnight RA Jhappan C et al. Ectopic TGFβ1 expression in the secretory mammary epithelium induces early senescence of the epithelial stem cell population Dev Biol 168 1995 47-61
59. Matsui Y Halter SA Holt JT et al. Development of mammary hyperplasia and neoplasia in MMTV-TGF alpha transgenic mice Cell 61 1990 1147-1156
60. Snedeker SM Brown CF Diaugustine RP. Expression and functional properties of TGF alpha and EGF during mouse mammary gland ductal morphogenesis Proc Natl Acad Sci USA 88 1991 276-280
61. Pierce Jr DF Gorska AE Chytil A et al. Mammary tumour suppression by transforming growth factor-β1 transgene expression Proc Natl Acad Sci USA 92 1995 4254-4258
62. Shull MM Ormbsy I Kier A et al. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease Nature 359 1992 693-699
63. Bottinger EP Jakubczak JL Haines DC et al. Transgenic mice over-expressing dominant-negative mutant type II transforming growth factor-β receptor show enhanced tumorigenesis in the mammary gland and lung in response to the carcinogen 7, 12 dimethylbenz-[a]-anthracene Cancer Res 57 1997 5564-5570
64. Tang B Bottinger EP Jakowlew SB et al. Transforming growth factor-β1 is a new form of tumor suppressor with true haploid insufficiency Nat Med 4 1998 802-807
65. Barlow J Yandell D Weaver D et al. Higher stromal expression of transforming growth factor-β type II receptors is associated with poorer prognosis breast tumours Breast Cancer Res Treat 79 2003 149-159
66. Dalal DI Keown PA Greenberg AH. Immunocytochemical localisation of secreted transforming growth factor-β1 to the advancing edges of primary tumours and to lymph node metastases of human mammary carcinoma Am J Pathol 43 1993 381-389
67. Walker RA Dearing SJ. Transforming growth factor-β1 in ductal carcinoma in situ and invasive carcinomas of the breast Eur J Cancer 28 1992 641-644
68. Yang EY Moses H. Transforming growth factor-β1 induced changes in cell migration proliferation and angiogenesis in the chicken chorioallantoic membrane J Cell Biol 111 1990 731-741
69. Wallick SC Figari IS Morris RE et al. Immunoregulatory role of transforming growth factor in development of killer cells: comparison of active and latent TGFβ1 J Exp Med 172 1990 1777-1784
70. Ziv E Cauley J Morin PA et al. Association between the T29→C polymorphism in the transforming growth factor β1 gene and breast cancer amongst elderly white women: the Study of Osteoporotic Fractures JAMA 285 2001 2859-2863
71. Yokota M. Association of a T29→C polymorphism of the transforming growth factor β1 gene with genetic susceptibility to myocardial infarction in Japanese Circulation 101 2000 2783-2787
72. Kaklamani VG Hou N Bian Y. TGFβ1*6A and cancer risk: a meta-analysis of seven case-control studies J Clin Oncol 21 2003 3236-3243
73. Kim SJ Jeang KT Glick AB et al. Promoter sequences of the human transforming growth factor-β1 gene responsive to transforming growth factor-β1 autoinduction J Biol Chem 264 1989 7041-7045
74. Arrick BA Grendell RL Griffin LA. Enhanced translational efficiency of a novel transforming growth factor-β3 mRNA in human breast cancer cells Mol Cell Biol 14 1994 619-628
75. Lee BI Park SH Kim JW et al. MS-275, a histone deacetylase inhibitor, selectively induces transforming growth factor β type II receptor expression in human breast cancer cells Cancer Res 61 2001 931-934
76. Kang SH Bang YJ Im YH et al. Transcriptional repression of the transforming growth factor-β type I gene by DNA methylation results in the development of TGFβ resistance in human gastric cancer Oncogene 18 1999 7280-7286
77. Villanueva A Garcia C Paules AB et al. Disruption of the anti-proliferative TGFβ signalling pathways in human pancreatic cancers Oncogene 17 1998 1969-1978
78. Mulder KM. Role of Ras and Mapks in TGFβ signalling Cytokine Growth Factor Rev 11 2000 23-25
79. Derynck R Akhurst RJ Balmain A. TGFβ signalling in tumor suppression and cancer progression Nat Genet 29 2001 117-129
80. Bubb VJ Curtis LJ Cunningham C et al. Microsatellite instability and the role of hMSH2 in sporadic colorectal cancer Oncogene 12 1996 2641-2649
81. Spearman M Taylor WR Greenberg AH et al. Anti-sense deoxyribonucleotide inhibition of TGFβ1 gene expression and alterations in the growth and malignant properties of mouse fibrosarcoma cells Gene 149 1994 25-29
82. Bandyopadhyay A Zhu Y Cibull ML et al. A soluble transforming growth factor-β type III receptor suppresses tumorogenicity and metastasis of human breast cancer MDA-MB-231 cells Cancer Res 59 1999 5041-5046
83. Bandyopadhyay A Zhu Y Malik SN et al. Extracellular domain of TGFβ type III receptor inhibits angiogenesis and tumour growth in human cancer cells Oncogene 21 2002 3541-3551
84. Park JA Wang E Kurt RA et al. Expression of an anti-sense transforming growth factor-β1 transgene reduces tumorogenicity of EMT6 mammary tumor cells Cancer Gene Ther 4 1997 42-50
85. Dumont N Arteaga CL. Targeting the TGFβ signalling network in human neoplasia Cancer Cell 3 2003 531-536